177 related articles for article (PubMed ID: 38346799)
1. Specific Alternation of Gut Microbiota and the Role of
Hong J; Fu T; Liu W; Du Y; Bu J; Wei G; Yu M; Lin Y; Min C; Lin D
J Microbiol Biotechnol; 2024 Mar; 34(3):547-561. PubMed ID: 38346799
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota dynamics in KK-Ay mice: restoration following antibiotic treatment.
Hong J; Fu T; Liu W; Yu M; Lin Y; Min C; Lin D
Folia Microbiol (Praha); 2024 Mar; ():. PubMed ID: 38536641
[TBL] [Abstract][Full Text] [Related]
3.
Zhou Q; Yang F; Li Z; Qu Q; Zhao C; Liu X; Yang P; Han L; Shi Y; Shi X
J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35617337
[TBL] [Abstract][Full Text] [Related]
4. Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4/NF-κB/NLRP3 signalling pathway.
Wang F; Liu C; Ren L; Li Y; Yang H; Yu Y; Xu W
Pharm Biol; 2023 Dec; 61(1):427-436. PubMed ID: 36772833
[TBL] [Abstract][Full Text] [Related]
5. Ruminococcus gnavus ameliorates atopic dermatitis by enhancing Treg cell and metabolites in BALB/c mice.
Ahn JR; Lee SH; Kim B; Nam MH; Ahn YK; Park YM; Jeong SM; Park MJ; Song KB; Lee SY; Hong SJ
Pediatr Allergy Immunol; 2022 Jan; 33(1):e13678. PubMed ID: 34633714
[TBL] [Abstract][Full Text] [Related]
6. Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota.
Hong J; Fu T; Liu W; Du Y; Bu J; Wei G; Yu M; Lin Y; Min C; Lin D
Diabetes Metab Syndr Obes; 2023; 16():3707-3725. PubMed ID: 38029001
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of a sialic acid metabolism pathway in mucus-foraging Ruminococcus gnavus unravels mechanisms of bacterial adaptation to the gut.
Bell A; Brunt J; Crost E; Vaux L; Nepravishta R; Owen CD; Latousakis D; Xiao A; Li W; Chen X; Walsh MA; Claesen J; Angulo J; Thomas GH; Juge N
Nat Microbiol; 2019 Dec; 4(12):2393-2404. PubMed ID: 31636419
[TBL] [Abstract][Full Text] [Related]
8. The role of the mucin-glycan foraging
Coletto E; Latousakis D; Pontifex MG; Crost EH; Vaux L; Perez Santamarina E; Goldson A; Brion A; Hajihosseini MK; Vauzour D; Savva GM; Juge N
Gut Microbes; 2022; 14(1):2073784. PubMed ID: 35579971
[No Abstract] [Full Text] [Related]
9. Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy.
Zhang L; Wang Z; Zhang X; Zhao L; Chu J; Li H; Sun W; Yang C; Wang H; Dai W; Yan S; Chen X; Xu D
Microbiol Spectr; 2022 Aug; 10(4):e0032422. PubMed ID: 35863004
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Dysbiosis Featuring Abundance of Ruminococcus gnavus Associates With Allergic Diseases in Infants.
Chua HH; Chou HC; Tung YL; Chiang BL; Liao CC; Liu HH; Ni YH
Gastroenterology; 2018 Jan; 154(1):154-167. PubMed ID: 28912020
[TBL] [Abstract][Full Text] [Related]
11. Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota.
Ni Y; Zheng L; Nan S; Ke L; Fu Z; Jin J
Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(10):1406-1420. PubMed ID: 36239349
[TBL] [Abstract][Full Text] [Related]
12. Magnesium lithospermate B ameliorates diabetic nephropathy by suppressing the uremic toxin formation mediated by gut microbiota.
Zhu N; Duan H; Feng Y; Xu W; Shen J; Wang K; Liu J
Eur J Pharmacol; 2023 Aug; 953():175812. PubMed ID: 37245856
[TBL] [Abstract][Full Text] [Related]
13. Corn silk polysaccharides attenuate diabetic nephropathy through restoration of the gut microbial ecosystem and metabolic homeostasis.
Dong W; Zhao Y; Li X; Huo J; Wang W
Front Endocrinol (Lausanne); 2023; 14():1232132. PubMed ID: 38111708
[TBL] [Abstract][Full Text] [Related]
14. Modulating the gut microbiota and inflammation is involved in the effect of Bupleurum polysaccharides against diabetic nephropathy in mice.
Feng Y; Weng H; Ling L; Zeng T; Zhang Y; Chen D; Li H
Int J Biol Macromol; 2019 Jul; 132():1001-1011. PubMed ID: 30946910
[TBL] [Abstract][Full Text] [Related]
15. Ruminococcus gnavus: friend or foe for human health.
Crost EH; Coletto E; Bell A; Juge N
FEMS Microbiol Rev; 2023 Mar; 47(2):. PubMed ID: 37015876
[TBL] [Abstract][Full Text] [Related]
16. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats.
Zhao T; Zhang H; Yin X; Zhao H; Ma L; Yan M; Peng L; Wang Q; Dong X; Li P
Biomed Pharmacother; 2020 Sep; 129():110325. PubMed ID: 32535383
[TBL] [Abstract][Full Text] [Related]
17. Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota.
Deng L; Yang Y; Xu G
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Dec; 1867(12):159234. PubMed ID: 36185030
[TBL] [Abstract][Full Text] [Related]
18. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.
Tao S; Li L; Li L; Liu Y; Ren Q; Shi M; Liu J; Jiang J; Ma H; Huang Z; Xia Z; Pan J; Wei T; Wang Y; Li P; Lan T; Tang X; Zeng X; Lei S; Tang H; Ma L; Fu P
Acta Diabetol; 2019 May; 56(5):581-592. PubMed ID: 30888537
[TBL] [Abstract][Full Text] [Related]
19. The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease.
Zhang L; Lu QY; Wu H; Cheng YL; Kang J; Xu ZG
Microbiol Spectr; 2023 Aug; 11(4):e0038223. PubMed ID: 37341590
[TBL] [Abstract][Full Text] [Related]
20. Ulinastatin ameliorated streptozotocin-induced diabetic nephropathy: Potential effects via modulating the components of gut-kidney axis and restoring mitochondrial homeostasis.
Rizk FH; El Saadany AA; Atef MM; Abd-Ellatif RN; El-Guindy DM; Abdel Ghafar MT; Shalaby MM; Hafez YM; Mashal SSA; Basha EH; Faheem H; Barhoma RA
Pflugers Arch; 2023 Oct; 475(10):1161-1176. PubMed ID: 37561129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
